Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

NCT00004154 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Fenretinide
OTHER: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]